Supriya Lifescience IPO Dates, Review, Price, Form, Lot size, & Allotment Details 2021

Supriya Lifescience IPO

Supriya Lifescience Ltd a pharmaceutical chemicals manufacturing company in India is preparing to launch a Supriya Lifescience IPO. For this, Supriya Lifescience Ltd has filed DRHP with market regulator SEBI. The company is raising funds of 1200 crores through this IPO. In which shares will be issued through 200 crores fresh equity issue and 1000 crore offer for sale. According to the company’s DRHP, this Supriya Lifescience IPO has reserved a quota of 75% for QIB Qualified Institutional Buyers, 15% for NII Non-Institutional Investors, and 10% for RII Retail Individual Investors.

Supriya Lifescience IPO will raise the fund to use reduce its Company Debt, Corporate use, and the company’s general operations. The main focus of the company is on development and research, the company has grown very well for the last several years.

Let me tell you that Supriya Lifescience Ltd is a company that manufactures pharmaceuticals ingredients (“APIs”). Which is constantly doing its development and research work. The company has 39 pharmaceutical APIs with products such as antihistamine, analgesic, anesthetic, vitamins, anti-asthma, and antiallergic. The company has been the largest exporter of Chlorpheniramine Malate and Ketamine. The company contributes 45–55% and 65–70% respectively to hydrochloride API exports. And it is one of the largest exporters of Salbutamol Sulfate from India.

Supriya Lifescience IPO Review :

■ Coming Soon

Supriya Lifescience IPO Date & Price Band & Details :

IPO Open :
IPO Close :
IPO Size :1200. Cr
Face Value :₹ 2 Rs. Equity Share
Price Band :– Per Share
Listing On :BSE, NSE
Issue Size :1200. Cr
Fresh Issue :200. Cr
Offer For Sale :1000. Cr

Supriya Lifescience IPO Market Lot :

Minimum Lot Size :
Minimum Amount :
Minimum Shares :– Share
Maximum shares:– Share

Supriya Lifescience IPO Shares Offer :

CategoryShares Offers
Fresh issue :
Offer For Sale :
Total :

Supriya Lifescience IPO Reservation :

CategoryReservationShares
QIB :75 %
NII :15 %
RII :10 %
EMP :– %
Total :100 %

Supriya Lifescience IPO Dates :

Allotment Date :May – June 2021
Refund Date :May – June 2021
Share Credit Date :May – June 2021
Listing Date :May – June 2021

Supriya Lifescience IPO Form :

There are two ways to apply in Supriya Lifescience IPO. You can apply for Supriya Lifescience IPO through ASBA available in your bank account. You have to go to your online bank login and select Supriya Lifescience IPO in the Invest section and apply through your bank account. Another option is you can apply Supriya Lifescience IPO through IPO form download through NSE and BSE. See the Supriya Lifescience IPO Form – Download the NSE Form and BSE Form IPO Form, fill it, and submit it to your bank or your broker.

Supriya Lifescience Company Financial Report (Cr) :

YearRevenueExpenseP&L
2021₹25,993.50₹23,694.00₹1,520.73
2020₹21,762.53₹21,377.81₹230.24
2019₹21,591.22₹21,037.06₹851.33

About Supriya Lifescience Company

Our Company was incorporated as ‘Supriya Lifescience Limited’ pursuant to a certificate of incorporation dated March 26, 2008, issued by the Registrar of Companies, Maharashtra at Mumbai (“RoC”), upon the conversion of ‘M/s Supriya Chemicals’, a partnership firm, into a public limited company, in accordance with the provisions of Part IX of the Companies Act, 1956. Our Company commenced operations pursuant to a certificate for commencement of business dated April 1, 2008, issued by RoC.

We are one of the key Indian manufacturers and suppliers of active pharmaceuticals ingredients (“APIs”), with a focus on research and development. As of March 31, 2021, we have niche product offerings of 39 APIs focused on diverse therapeutic segments such as antihistamine, analgesic, anesthetic, vitamin, anti-asthmatic and antiallergic. We have consistently been the largest exporter of Chlorpheniramine Maleate and Ketamine Hydrochloride from India, contributing to 45-55% and 65-70%, respectively, of the API exports from India, between Fiscal 2017 and 2020. We were among the largest exporters of Salbutamol Sulphate from India in Fiscal 2020 in terms of volume.

  • Europe, which contributed to 25.81% of revenue from operation for the nine-month period ended December 31, 2020.
  • Latin America, which contributed 12.37% of revenue from operation for the nine-month period ended December 31, 2020.
  • Asia (excluding India), which contributed to 24.19% of revenue from operation for the nine-month period ended December 31, 2020.
  • North America (including Canada), which contributed to 6.16% of revenue from operation for the nine-month period ended December 31, 2020.
  • India, which contributed to 23.63% of revenue from operation for the nine month period ended December 31, 2020.

Company Strenghts

Our core strength lies in identifying generic molecules (off-patent) in our existing therapeutic segments which fits into our existing chemistry and production infrastructure and our ability to develop the product and scale up production. In order to achieve the same, our marketing and research, and development teams work in tandem to estimate the potential market (in terms of volume) and cost of development, raw materials, and production. With our focus on products that are high on value and low on competition, we are well-positioned to derive relatively higher returns from our investments.

Company Promoters :

■ Satish Waman Wagh

Supriya Lifescience Board of Directors

NameDesignation
Satish Waman WaghChairman and Managing Director
Smita Satish WaghWhole-time Director
Saloni Satish WaghWhole-time Director
Shivani Satish WaghWhole-time Director
Balasahab Gulabrao SawantWhole-time Director
Kedar Shankar KarmarkarIndependent Director
Bhairav Manojbhai ChokshiIndependent Director
Dileep Kumar JainAdditional Independent Director
Dinesh Navnitlal ModiAdditional Independent Director
Neelam Yashpal AroraAdditional Independent Director

Quick Link :

■ DRHP Draft Prospectus

Supriya Lifescience IPO Lead Managers :

■ ICICI Securities Limited

■ Axis Capital Limited

Supriya Lifescience IPO Registrar :

Link Intime India Private Limited
C-101, 247 Park, 1
st Floor,
L.B.S. Marg, Vikhroli West
Mumbai 400 083
Maharashtra, India
Tel: +91 22 4918 6200
E-mail: [email protected]
Website: www.linkintime.co.in

Note: Check Supriya Lifescience IPO allotment status Visit IPOBAZAR Allotment Page And Search Your Registrar IPO Allotment Link. Click Here

Company Address :

Registered and Corporate Office of our Company
207/208, Udyog Bhavan,
Sonawala Road,
Goregaon (East),
Mumbai – 400 063
Tel: +91 22 40332727

Website: www.supriyalifescience.com

Supriya Lifescience IPO FAQs :

What is Supriya Lifescience IPO?

Supriya Lifescience IPO is Main Board IPO. They are going to raise ₹1200. Crores via IPO. The issue is priced at ₹- to ₹- per equity share. The IPO to be listed on BSE & NSE.

When Supriya Lifescience IPO will open?

The IPO is to open on May – June 2021 for QIB, NII & RII.

What is Supriya Lifescience IPO Size?

Supriya Lifescience IPO size is ₹1200 Crores.

What is the Fresh issue size of Supriya Lifescience IPO?

The Fresh issue size of Supriya Lifescience IPO ₹200 Cr.

What is the Offer For Sale size of Supriya Lifescience IPO?

The Offer For Sale size of Supriya Lifescience IPO ₹1000 Cr.

What is Supriya Lifescience IPO Price Band?

Supriya Lifescience IPO Price Band is ₹- to ₹-.

What is Supriya Lifescience IPO Minimum and Maximum Lot Size?

The minimum bid is – Shares with ₹- amount while maximum bid is – shares with ₹-

What is Supriya Lifescience IPO Investors Portion?

The investors’ portion for QIB 75%, NII 15%, RII 10%.

What is Supriya Lifescience IPO Allotment Date?

Supriya Lifescience IPO allotment date is Not Declare.

What is Supriya Lifescience IPO Listing Date?

Supriya Lifescience IPO listing date is Not Declare. The IPO to list on BSE and NSE.

How to Apply the Supriya Lifescience IPO through Zerodha?

Log in to Console in Zerodha Website. Go to Portfolio and Click on IPO. You will see the IPO Name “Supriya Lifescience IPO”. Click on Bid Button. Enter your UPI ID, Quantity, and Price. Submit IPO Application Form. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate.

How to Apply the Supriya Lifescience IPO through Upstox?

Log in to Upstox Website or app. Go to Portfolio and Click on IPO. You will see the IPO Name “Supriya Lifescience IPO”. Click on Bid Button. Enter your UPI ID, Quantity, and Price. Submit IPO Application Form. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate.

How to Apply the Supriya Lifescience IPO through Groww?

Log in to Groww Website or app. Now you can see IPOs and Click on IPO. You will see the IPO Name “Supriya Lifescience IPO”. Click on Bid Button. Enter your UPI ID, Quantity, and Price. Submit IPO Application Form. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate.

How to Apply the Supriya Lifescience IPO through Paytm Money?

Log in to the Paytm Money Website or app. Now you can see Invest is IPOs Section and Click on IPO. You will see the IPO Name “Supriya Lifescience IPO”. Click on Bid Button. Enter your UPI ID, Quantity, and Price. Submit IPO Application Form. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate.

Supriya Lifescience IPO GMP: Click Here

Supriya Lifescience IPO Subscription Status: Click Here

Supriya Lifescience IPO Allotment: Click Here

Supriya Lifescience IPO Listing: Click Here

Disclaimer: STOCK MARKET INVESTMENTS ARE SUBJECT TO MARKET RISKS, READ ALL SCHEME RELATED DOCUMENTS CAREFULLY.

Supriya Lifescience IPO Dates, Review, Price, Form, Lot size, & Allotment Details 2021
1Shares
error: Content is protected !!